Celixir Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

Celixir General Information

Description

Developer of cell and gene therapies designed to treat cancer, heart failure, and other incurable diseases. The company's medicines consist of iMP cells, platelet lysate, and PML cells to treat patients with ischaemic heart disease, injured tendons near the surface of the skin, and mild to moderate heart failure, respectively, enabling medical researchers to discover breakthrough medicines that aim to change the standard of medical care for patients.

Contact Information

Website
www.celixir.com
Formerly Known As
Cell Therapy
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Celixir House, Innovation Way
  • Stratford Business and Technology Park, Banbury Road
  • Stratford-upon-Avon CV37 7GZ
  • England, United Kingdom
+44 029
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • Celixir House, Innovation Way
  • Stratford Business and Technology Park, Banbury Road
  • Stratford-upon-Avon CV37 7GZ
  • England, United Kingdom
+44 029

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celixir Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Secondary Transaction - Private 01-Oct-2025 Completed Generating Revenue
10. Later Stage VC Completed Generating Revenue
9. Reverse Merger 17-Aug-2023 Cancelled Generating Revenue
8. PIPE 24-Jan-2024 Cancelled Generating Revenue
7. Later Stage VC Completed Clinical Trials - Phase 3
6. Later Stage VC 01-Jan-2020 Completed Clinical Trials - Phase 3
5. Later Stage VC 21-Mar-2018 Completed Startup
4. Angel (individual) 16-Aug-2017 Completed Startup
3. Equity Crowdfunding 09-Dec-2014 $1.08M $1.12M Completed Startup
2. Accelerator/Incubator 07-Mar-2013 $40K $40K Completed Startup
To view Celixir’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Celixir Patents

  • 118

    Total Documents Applications and Grants

  • Total Patents Families

  • 51

    Granted

  • 8

    Pending

  • Expiring in next 12 mo

Celixir Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202003678-D0 Stat6 inhibiting composition Inactive 13-Mar-2020
GB-201916842-D0 Mesodermal killer (mk) cell Inactive 19-Nov-2019
AU-2020209441-A1 Mesodermal killer (mk) cell Active 15-Jan-2019
AU-2020209441-B2 Mesodermal killer (mk) cell Active 15-Jan-2019
CA-3126744-A1 Mesodermal killer (mk) cell Pending 15-Jan-2019 A61K40/10
To view Celixir’s complete patent history, request access »

Celixir Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Celixir Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Regah Ventures Venture Capital Minority
UK Innovation & Science Seed Fund Venture Capital Minority
Swansea University University
Blueray Capital Lender/Debt Provider Minority
Boundary Capital Partners Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Celixir Acquisitions (1)

Celixir’s most recent deal was a Merger/Acquisition with Genomes Unzipped. The deal was made on 01-Jun-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Genomes Unzipped 01-Jun-2018 Merger/Acquisition Information Services (B2C)
To view Celixir’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Celixir Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Genomes Unzipped Stratford-Upon-Avon, United Kingdom 2012

Celixir FAQs

  • When was Celixir founded?

    Celixir was founded in 2009.

  • Where is Celixir headquartered?

    Celixir is headquartered in Stratford-upon-Avon, United Kingdom.

  • What is the size of Celixir?

    Celixir has 8 total employees.

  • What industry is Celixir in?

    Celixir’s primary industry is Drug Discovery.

  • Is Celixir a private or public company?

    Celixir is a Private company.

  • What is Celixir’s current revenue?

    The current revenue for Celixir is .

  • How much funding has Celixir raised over time?

    Celixir has raised $8.63M.

  • Who are Celixir’s investors?

    Regah Ventures, UK Innovation & Science Seed Fund, Swansea University, Blueray Capital, and Boundary Capital Partners are 5 of 7 investors who have invested in Celixir.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process